• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Skin Microbiota
      • Anti-oxidant
        • Oxidative stress
        • Lipid peroxidation
        • Glutathione Stock
      • Wound Healing
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter

hcs pharma

News

Vaihere joins us as a lab technician

Vaihere Cheung obtained her technology A-level (STL) in 2018 at La Mennais, in French Polynesia. Then she came to metropolitan France to reach a technician diploma in Biological engineering, specialized in biological and biochemical analysis, at the University of Lyon. During her studies, Vaihere did an internship in HCS Pharma Read more…

By Véronique De Conto, 5 months3 months ago
Biomimesys

BIOMIMESYS® for assessing anti-cancer treatments

This summer, Vitali et al. published an article in the Open Access Journal Cancers in which they assessed anticancer combination to treat neuroendocrine tumors (NETs) using in vitro models (2D + 3D cultures in BIOMIMESYS hydroscaffolds). A NET arises in the specialized cells of the neuroendocrine system, which have traits of Read more…

By Elodie Vandenhaute, 5 months3 months ago
Biomimesys

Feedback from Molecular Devices’ User Meeting in Leiden

Just before Covid-19 pandemic crisis widely spread to France, we attended the User Meeting organized by Molecular Devices in Hilton Garden Inn Leiden (Oegstgeest, Netherlands). We enjoyed the programme, gathering a variety of topics but with high content analysis/screening as a common technique to answer diverse scientific questions. On the Read more…

By Elodie Vandenhaute, 12 months3 months ago
News

COVID-19 pandemic impacts HCS Pharma activities

As many companies in France and in the world, the COVID-19 pandemic deeply affects our activities. For safety reasons, most of our work is now done remotely but we maintain essential activity in laboratories to take care of our cells and try to finish our ongoing customer studies. The situation Read more…

By Grégory MAUBON, 12 months3 months ago
BioPharMEMS

LabCom grant for HCS Pharma, SMMiL-E team and IEMN

We are happy to tell you that HCS Pharma, SMMiL-E team (Seeding Microsystems in Medecine in Lille – European-Japanese Technologies against Cancer, CNRS UMI-2820 LIMMS/IIS) and Institut d’Electronique, de Micro-Electronique et de Nanotechnologie (IEMN) have successfully applied to a LabCom grant (‘COMmon LABoratory’)! A LabCom aims at gathering two entities Read more…

By Elodie Vandenhaute, 1 year3 months ago
HCS, HCA & Biology

Regenerative medicine in stroke

Stroke is the second leading cause of death worldwide and the most common cause of disability in adults. Ischemic stroke represents 80% of the cases. They cause oxygen and glucose deficit in the brain, leading to necrosis, edema formation, inflammation and apoptosis. Endogenous repair mechanisms, like cerebral plasticity, limit ischemia-linked Read more…

By Véronique De Conto, 1 year11 months ago
News

Feedback from BioFit 2019 in Marseille

Nathalie and Elodie were in Marseille last week for BioFit event, where we had a booth under Clubster NHL (Nutrition-Health-Longevity) Pavilion: We would like to thank all the participants and collaborators who came to see us… We really enjoyed spending these 2 days with our neighbours from InEye-Pharma and ImmuneInsight: Read more…

By Elodie Vandenhaute, 1 year3 months ago
News

We’ll be at BioFit next week (with a great offer)!

Nathalie and Elodie will be present in Marseille for BioFit event next week! Indeed, HCS Pharma has a booth in Clubster NSL’s pavilion (number I20). Just stop by 🙂 It will be a pleasure to talk to you about the innovative 3D cell culture matrix BIOMIMESYS® and our related services Read more…

By Elodie Vandenhaute, 1 year3 months ago
News

Feedback from the congress of Centers of Excellence in Neurodegeneration (CoEN)

The 2nd congress of Centers of Excellence in Neurodegeneration (CoEN) took place in Lille on the 14th and 15th of November 2019. It was organized by the Lille Center of Excellence for Neurodegenerative Disorders (LICEND). This meeting welcomed seven French research centers of excellence in neurodegenerative diseases: Lille (LICEND), CoEN Read more…

By Véronique De Conto, 1 year3 months ago
News

Feedback from NutrEvent 2019 in Rennes

Last week, our study director Elodie was in Rennes to participate in NutrEvent! We had a booth there, under NSL Clubster pavilion (Lille Northern France Health and Nutrition clubster). It was a pleasure for her to present our activities in imaging and our 3D cell culture products to the visitors! Read more…

By Elodie Vandenhaute, 1 year3 months ago
News

Meet HCS Pharma @ Nutrevent in Rennes next week!

With more than 25 countries represented, NutrEvent is THE place to be for business and innovation in Food, Nutrition and Health. It will take place next week in Rennes congress centre (Couvent des Jacobins), on the 22nd and 22rd of October. Our stand will be on Eurasanté Pavilion (Level 1 Read more…

By Elodie Vandenhaute, 1 year3 months ago
News

Kick-off meeting of ANR-funded project MIMLIVEROnChip

Last week we were glad to attend the kick-off meeting of MIMLIVEROnChip, funded by the french National Agency for Research (ANR). It was held in UTC Compiègne, and the project is coordinated by Pr Cecile Legallais (BIOMÉCANIQUE ET BIOINGÉNIERIE (BMBI Laboratory) – UMR CNRS 7338). This project aims at developing Read more…

By Elodie Vandenhaute, 1 year3 months ago
News

Merci à Eurasanté pour ce moment festif et convivial !

Elodie, Véronique et Océane ont profité d’un moment très sympathique – et ensoleillé – lors du barbecue du parc Eurasanté ce midi… Merci à tous, et bon week-end 🙂

By Elodie Vandenhaute, 2 years3 months ago
News

HCS Pharma @ Forum Labo Paris 2019

Last week HCS Pharma team enjoyed Forum Labo Paris! We enjoyed it twofold because : we won our booth on the Lab’StartUp Village, in the heart of the fair. It gave us the opportunity to present our BIOMIMESYS® products! we won a price for our amazing photo of liver cells… Read more…

By Elodie Vandenhaute, 2 years3 months ago
News

Feedback from HCS Pharma @ HI Europe Frankfurt 2018!

Our study directors Elodie and Pierre-Jean enjoyed the last edition of Health Ingredients Europe, which took place in Frankfurt (Germany) from the 27th to the 28th of November 2018. For their first time in HIE, they appreciated the organization and size of the salon, as well as the networking opportunities Read more…

By Elodie Vandenhaute, 2 years3 months ago
Prof. Dominique Collard
News

Second scientific advisory board meeting for HCS Pharma Lille!

HCS pharma has organized its second scientific advisory board! We were pleased to gather around the table (physically or via a Webex visioconference for those who could not make the trip) David Devos, Roméo Cecchelli, George Haase, Karim Si Tayed… and a new board member:  Dominique Collard! Dominique is known Read more…

By Elodie Vandenhaute, 3 years4 weeks ago
News

Feedback from COSMED Event : new norms and new expectations in cosmetics

Last week, we attended to the 6th edition of COSMED Meeting in the west of France. We would like to thank the organisation team of COSMED for giving us the opportunity to attend to this event. During this day we have visited the new facilities of Technature, a famous french  cosmetic manufacturer Read more…

By Léo Mall, 3 years3 months ago
News

Our first scientific advisory board meeting in HCS Pharma

We were really pleased to organize our first scientific advisory board last week

By Nathalie MAUBON, 3 years3 months ago
News

Do you want to visit our offices with TVRennes ?

Few days ago, #tv Rennes, the TV channel of the Rennes City, came to our labs and wanted to know more about our business. Let’s discover it (in french) !

By Grégory MAUBON, 6 years3 months ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • How to create physiologically-relevant 3D in vitro models using BIOMIMESYS® hydroscaffold
  • The skin microbiota, a fundamental part of in vitro studies
  • Agrément CIR jusqu’en 2023 pour HCS Pharma
  • Oxidative stress : definition and biological effects
  • On the importance of extracellular matrix of the skin for efficient 3D cell culture models
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell CHOPIN congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix forum labo genotoxicity HCA HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro liver meeting Microbiota microenvironment microscopy model Molecular Devices NEUROCELL3D neurotoxicity oncology Parkinson phenotypic screening picture rennes screening skin toxicology
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2020 | Hestia | Powered by WordPress